Qinghai Spring Medicinal Resources Technology Co., Ltd.
600381.SS · SHH
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | CN¥3 | CN¥2 | CN¥3 | CN¥2 |
| - Cash | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| + Debt | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Enterprise Value | CN¥3 | CN¥2 | CN¥2 | CN¥2 |
| Revenue | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Growth | 110.1% | -50.6% | 15.7% | – |
| Gross Profit | CN¥0 | CN¥0 | CN¥0 | -CN¥0 |
| % Margin | 27% | 63% | 60.6% | -10.4% |
| EBITDA | -CN¥0 | CN¥0 | CN¥0 | -CN¥0 |
| % Margin | -3.7% | 3.4% | 7% | -160.8% |
| Net Income | -CN¥0 | -CN¥0 | CN¥0 | -CN¥0 |
| % Margin | -4.8% | -18.4% | 10.7% | -150% |
| EPS Diluted | -0.007 | -0.013 | 0.016 | -0.19 |
| % Growth | 45.9% | -185.3% | 108.2% | – |
| Operating Cash Flow | -CN¥0 | CN¥0 | -CN¥0 | CN¥0 |
| Capital Expenditures | -CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |
| Free Cash Flow | -CN¥0 | CN¥0 | -CN¥0 | CN¥0 |